| CTSU - RECORDED Workshop |
|
| 18/08/2022 |
Until end 2022 |
20220316 - OAC job presentation |
Justine Severs |
Finished
|
| 25/03/2021 |
16:05-16:50 |
HER2 Positive metastatic breast cancer: current option and future treatments |
Philippe Aftimos, MD |
Finished
|
| 25/03/2021 |
16:50-17:30 |
Treatment for TBNC early Breast Cancer |
Michail Ignatiadis, MD, PhD |
Finished
|
| 25/03/2021 |
17:45-18:30 |
Early HER2 Positive Breast Cancer: What are the treatment options in 2021? |
Martine Piccart, MD, PhD |
Finished
|
| 25/03/2021 |
18:30-19:00 |
Live Q&A |
E.De Azambuja, MD, PhD; P.Aftimos, MD; M.Ignatiadis, MD, PhD and M.Piccart, MD, PhD |
Finished
|
| Friday 26th March, 2021 |
|
| 26/03/2021 |
15:00-16:00 |
Targeted Therapies Immunotherapy and New Cytotoxics in the Management of Breast Cancer: New Therapeutic Algorithms (General Overview) |
Ahmad Awada, MD, PhD |
Finished
|
| 26/03/2021 |
16:00-16:30 |
Pathological characterization of breast cancer: Molecular prognostic and predictive markers |
Roberto Salgado, MD, PhD |
Finished
|
| 26/03/2021 |
16:45-18:45 |
Live Q&A + clinical cases discussion |
A.Awada MD, PhD; R.Salgado, MD, PhD; E.De Azambuja, MD, PhD; P.Aftimos, MD; M.Ignatiadis, MD, PhD and M.Piccart, MD, PhD |
Finished
|
